tirzepatide on shortage list FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now Article » Proact Pharmacy Services

The dual GIP and GLP-1 agonism of tirzepatide offers slightly different metabolic effects that may overcome semaglutide resistance

Like Mounjaro, retatrutide is a GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide1) agonist

Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease

Jastreboff and colleagues studied the obesity Phase 2 in NEJM observing mean body weight reduction reaching approximately 24 percent at the 12 mg dose tier at 48 weeks (PMID 37366315)

2024 Dec : Added section on classical and non-classical congenital adrenal hyperplasia (CAH and NC-CAH) to Causes of Female Infertility Jan : Added section on dehydroepiandrosterone (DHEA) to Nutrients 2023 Apr : Updated Dietary & Lifestyle Changes section to include discussion of sleep apnea in Maintaining healthy sleep habits 2022 Jul : Initial publication Disclaimer and Safety Information This information (and any accompanying material) is not intended to replace the attention or advice of a physician or other qualified health care professional

The following sections highlight key considerations for refining dosing protocols based on experimental design